Search the Newsreel

Fresenius Medical Care AG (FMS) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Fresenius Medical Care AG: Ergebnis verfehlt Analystenschätzungen: Das prognostizieren Analysten jetzt

Fresenius Medical Care (FMC) St-Aktie: DZ BANK vergibt Bewertung mit Kaufen

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

Fresenius Medical Care AG FMS reported second-quarter 2026 adjusted earnings per share (EPS) of 66 cents, which increased 28% year over year at constant currency (cc), supported by stronger Care Delivery profitability and share repurchases. FMS Posts Solid Organic Revenue Growth Revenues rose 0.9% …

Fresenius Medical Care (XTRA:FME) Expands BEACON US To Build Its Case For HVHDF

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fresenius Medical Care is expanding its BEACON-US clinical initiative to build real-world evidence for high-volume hemodiafiltration therapy in the U.S. The program evaluates …

UBS AG verleiht Fresenius Medical Care (FMC) St-Aktie Sell in jüngster Analyse

Fresenius Medical Care (XTRA:FME) Stock Looks Like A Bargain Despite Weak Returns

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Fresenius Medical Care stock has recovered modestly in the short term yet is still down about 30% over the past five years, while recent valuation checks suggest …

Is Fresenius Medical Care (XTRA:FME) Undervalued Following Its New CEO Appointment?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fresenius Medical Care (XTRA:FME) has drawn fresh attention after the Supervisory Board appointed Cassie McLean as Management Board member and Chief Executive Officer …

Fresenius Medical Care targets ~20% 5008X conversion in 2026 while keeping operating income guidance at mid-single-digit % change

Earnings Call Insights: Fresenius Medical Care (FMS) Q2 2026 MANAGEMENT VIEW * "We continued our strong start to the year, delivering another quarter of highly profitable growth" (Chair of Management Board & CEO Helen Giza). She said operating income growth "accelerated to 23%" and …

Fresenius Medical Care AG (FMS) (Q2 2026) Earnings Call Highlights: Strong Profit Growth and ...

This article first appeared on GuruFocus. Revenue: Solid organic group revenue growth of 5% in Q2, with a 4% increase at constant currency. Operating Income: Increased significantly by 23% at constant currency, with growth accelerating and in line with planned phasing for 2026. Operating …

Future Metals Reaffirms Robust Data Behind High-Grade Panton Platinum Project

Future Metals weighs dual development paths in updated Panton scoping study

Fresenius Medical Care Shares Slide Despite Second-Quarter Earnings Beat

Researcher looking through microscope ©Adobe Stock Images Fresenius Medical Care (NYSE:FMS) shares fell 8.0% to €41.285 during Tuesday's trading session as investors looked beyond better-than-expected second-quarter results and focused instead on continued weakness in U.S. patient treatment volumes. Although the dialysis provider exceeded analyst …

Fresenius Medical Care Aktie: US-Geschäft bremst weiter

Fresenius Medical Care Aktie deutlich tiefer - Gründe für den starken Rückgang - 04.08.2026

Trending Stocks Today: CFMEE Surges 20.56%

Future Metals NL (ASX:FME) Share Price Climbs 16% on Tuesday – Here’s What Happening

Future Metals NL Issues Unquoted Incentive Securities to Staff

Fresenius Medical Care GAAP EPS of EUR0.81, revenue of EUR4.86B

* Fresenius Medical Care press release [https://seekingalpha.com/pr/20604629-fresenius-medical-care-accelerates-income-growth-to-23-percent-in-the-second-quarter-of-2026] (FMS [https://seekingalpha.com/symbol/FMS]): Q2 GAAP EPS of EUR0.81. * Revenue of EUR4.86B. MORE ON FRESENIUS MEDICAL CARE * Fresenius Medical Care: More Favorable Patient Outcomes Will Drive Growth [https://seekingalpha.com/article/4923734-fresenius-medical-care-more-favorable-patient-outcomes-will-drive-growth] * Fresenius Medical: High Yield, Utilities-Like Stock At Valuation …

Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery

BAD HOMBURG, Germany, Aug. 3, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease, has appointed Cassie McLean (48) as a member of the Management Board, effective 1 August …

Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda

Organic revenue growth1 of 5% with growth in all operating segments Operating income2 grew by 23%, resulting in further margin expansion to 11.7% Reported operating income grew by 10% and reported net income3 decreased by 3% Earnings per share2 (EPS) increased by 28%, supported …

Fresenius Medical Care mit mehr Umsatz und Gewinn als erwartet - Prognose bleibt

Fresenius Medical Care Aktie: Ergebnis schlägt Erwartungen

Fresenius Medical Care mit mehr Umsatz und Gewinn als erwartet - Aktie steigt

Die Fresenius-Medical-Care-Aktie zeigt Stabilität nach jüngsten Quartalszahlen

Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients

BEACON-US research initiative is evaluating the clinical outcomes and patient experiences of high-volume hemodiafiltration in routine U.S. clinical practice across diverse patient populations Fresenius Medical Care expands access to the therapy across the U.S. building on two decades of evidence and treatment from over …

Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

This article first appeared on GuruFocus. Release Date: July 23, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Quest Diagnostics Inc (NYSE:DGX) reported a strong revenue growth of over 10% in the second …

Deutsche Bank AG bescheinigt Hold für Fresenius Medical Care (FMC) St-Aktie

Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy

Cloud-based platform provides retrospective, program-level insight into kidney replacement therapy delivered in acute and hospital critical care settings Available within NxStage® System One™ with NxView™ 4.0, Fresenius Medical Care's FDA 510(k)-cleared software platform for kidney replacement therapy in the United States Aggregates existing therapy …

Future Metals (ASX:FME) Tumbles Nearly 17%: Is Value Left in This Battered Miner?

DAX Verlierer heute: Fresenius Medical Care unter Druck - Hannover Rück Aktie im Fokus

Earnings Call: Fresenius Medical Care übertrifft im 1. Quartal 2026 die Gewinnerwartungen, verfehlt aber die Umsatzprognose

Fresenius Medical Care-Aktie: Jetzt schon einsteigen?